Crosstalk between PI3K/Akt and Wnt/β-catenin pathways promote colorectal cancer progression regardless of mutational status

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhao M, Yin J, Lu T, Yang X, Yuan G, Li M, Liu Y, Zhan C, Wang Q. Pulmonary metastasis in newly diagnosed colon-rectal cancer: a population-based nomogram study. Int J Colorectal Dis. 2019;34(5):867–878. doi:10.1007/s00384-019-03270-w.
   PubMed Web of Science ®Google Scholar
• Nusse R, Clevers H. Wnt/β-Catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169(6):985–999. doi:10.1016/j.cell.2017.05.016.
   PubMed Web of Science ®Google Scholar
• Riemer P, Rydenfelt M, Marks M, van Eunen K, Thedieck K, Herrmann BG, Blüthgen N, Sers C, Morkel M. Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids. J Cell Biol. 2017;216(6):1567–1577. doi:10.1083/jcb.201610058.
   PubMed Web of Science ®Google Scholar
• Mei ZB, Duan CY, Li CB, Cui L, Ogino S. Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysis. Ann Oncol. 2016;27(10):1836–1848. doi:10.1093/annonc/mdw264.
   PubMed Web of Science ®Google Scholar
• Ogino S, Lochhead P, Giovannucci E, Meyerhardt JA, Fuchs CS, Chan AT. Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology. Oncogene. 2014;33(23):2949–2955. doi:10.1038/onc.2013.244.
   PubMed Web of Science ®Google Scholar
• Bahrami A, Khazaei M, Hasanzadeh M, ShahidSales S, Joudi Mashhad M, Farazestanian M, Sadeghnia HR, Rezayi M, Maftouh M, Hassanian SM, et al. Therapeutic potential of targeting PI3K/AKT pathway in treatment of colorectal cancer: rational and progress. J Cell Biochem. 2018;119(3):2460–2469. doi:10.1002/jcb.25950.
   PubMed Web of Science ®Google Scholar
• Bendell JC, Rodon J, Burris HA, de Jonge M, Verweij J, Birle DD, De Buck SS D, Ru QC, Peters M, Goldbrunner M, et al. Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors. J Clin Oncol. 2012;30(3):282–290. doi:10.1200/JCO.2011.36.1360.
   PubMed Web of Science ®Google Scholar
• Courtney KD, Corcoran RB, Engelman JA. The PI3K pathway as drug target in human cancer. J Clin Oncol. 2010;28(6):1075–1083. doi:10.1200/JCO.2009.25.3641.
   PubMed Web of Science ®Google Scholar
• Markman B, Atzori F, Pérez-García J, Tabernero J, Baselga J. Status of PI3K inhibition and biomarker development in cancer therapeutics. Ann Oncol. 2010;21(4):683–691. doi:10.1093/annonc/mdp347.
   PubMed Web of Science ®Google Scholar
• Anastas JN, Moon RT. WNT signaling pathways as therapeutic targets in cancer. Nat Rev Cancer. 2013;13(1):11–26. doi:10.1038/nrc3419.
   PubMed Web of Science ®Google Scholar
• Arqués O, Chicote I, Puig I, Tenbaum SP, Argilés G, Dienstmann R, Fernández N, Caratù G, Matito J, Silberschmidt D, et al. Tankyrase inhibition blocks Wnt/β-Catenin pathway and reverts resistance to PI3K and AKT inhibitors in the treatment of colorectal cancer. Clin Cancer Res. 2016;22(3):644–656. doi:10.1158/1078-0432.CCR-14-3081.
   PubMed Web of Science ®Google Scholar
• Hakuno F, Takahashi SI. IGF1 receptor signaling pathways. J Mol Endocrinol. 2018;61(1):T69–T86. doi:10.1530/JME-17-0311.
   PubMed Web of Science ®Google Scholar
• Qi L, Sun B, Liu Z, Cheng R, Li Y, Zhao X. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression. J Exp Clin Cancer Res. 2014;33(1):107. doi:10.1186/s13046-014-0107-4.
   PubMedGoogle Scholar
• Gui S, Yuan G, Wang L, Zhou L, Xue Y, Yu Y, Zhang J, Zhang M, Yang Y, Wang DW. Wnt3a regulates proliferation, apoptosis and function of pancreatic NIT-1 beta cells via activation of IRS2/PI3K signaling. J Cell Biochem. 2013;114(7):1488–1497. doi:10.1002/jcb.24490.
   PubMed Web of Science ®Google Scholar
• Laguë MN, Paquet M, Fan HY, Kaartinen MJ, Chu S, Jamin SP, Behringer RR, Fuller PJ, Mitchell A, Doré M, et al. Synergistic effects of Pten loss and WNT/CTNNB1 signaling pathway activation in ovarian granulosa cell tumor development and progression. Carcinogenesis. 2008;29(11):2062–2072. doi:10.1093/carcin/bgn186.
   PubMed Web of Science ®Google Scholar
• Ormanns S, Neumann J, Horst D, Kirchner T, Jung A. WNT signaling and distant metastasis in colon cancer through transcriptional activity of nuclear β-Catenin depend on active PI3K signaling. Oncotarget. 2014;5(10):2999–3011. doi:10.18632/oncotarget.1626.
   PubMedGoogle Scholar
• Hermida MA, Dinesh Kumar J, Leslie NR. GSK3 and its interactions with the PI3K/AKT/mTOR signaling network. Adv Biol Regul. 2017;65:5–15. doi:10.1016/j.jbior.2017.06.003.
   PubMedGoogle Scholar
• Li XL, Zhou J, Chen ZR, Chng WJ. P53 mutations in colorectal cancer - molecular pathogenesis and pharmacological reactivation. World J Gastroenterol. 2015;21(1):84–93. doi:10.3748/wjg.v21.i1.84.
   PubMed Web of Science ®Google Scholar
• Schell MJ, Yang M, Teer JK, Lo FY, Madan A, Coppola D, Monteiro AN, Nebozhyn MV, Yue B, Loboda A, et al. A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC. Nat Commun. 2016;7(1):11743. doi:10.1038/ncomms11743.
   PubMedGoogle Scholar
• Lin M-W, Su K-Y, Su T-J, Chang -C-C, Lin J-W, Lee Y-H, Yu S-L, Chen J-S, Hsieh M-S. Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer. Lung Cancer. 2018;125:282–290. doi:10.1016/j.lungcan.2018.10.006.
   PubMed Web of Science ®Google Scholar
• Wagner AH, Devarakonda S, Skidmore ZL, Krysiak K, Ramu A, Trani L, Kunisaki J, Masood A, Waqar SN, Spies NC, et al. Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer. Nat Commun. 2018;9(1):3787. doi:10.1038/s41467-018-06162-9.
   PubMedGoogle Scholar
• Morrow CJ, Gray A, Dive C. Comparison of phosphatidylinositol-3-kinase signaling within a panel of human colorectal cancer cell lines with mutant or wild-type PIK3CA. FEBS Lett. 2005;579(23):5123–5128. doi:10.1016/j.febslet.2005.07.096.
   PubMed Web of Science ®Google Scholar
• Vasudevan KM, Barbie DA, Davies MA, Rabinovsky R, McNear CJ, Kim JJ, Hennessy BT, Tseng H, Pochanard P, Kim SY, et al. AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer. Cancer Cell. 2009;16(1):21–32. doi:10.1016/j.ccr.2009.04.012.
   PubMed Web of Science ®Google Scholar
• Ding VW, Chen R-H, McCormick F. Differential Regulation of Glycogen Synthase Kinase 3β by Insulin and Wnt Signaling. J Biol Chem. 2000;275(42):32475–32481. doi:10.1074/jbc.M005342200.
   PubMed Web of Science ®Google Scholar
• Ng SS, Mahmoudi T, Danenberg E, Bejaoui I, de Lau W, Korswagen HC, Schutte M, Clevers H. Phosphatidylinositol 3-kinase signaling does not activate the wnt cascade. J Biol Chem. 2009;284(51):35308–35313. doi:10.1074/jbc.M109.078261.
   PubMed Web of Science ®Google Scholar
• Fukumoto S, Hsieh CM, Maemura K, Layne MD, Yet SF, Lee KH, Matsui T, Rosenzweig A, Taylor WG, Rubin JS, et al. Akt participation in the Wnt signaling pathway through disheveled. J Biol Chem. 2001;276(20):17479–17483. doi:10.1074/jbc.C000880200.
   PubMed Web of Science ®Google Scholar
• Kim SE, Lee WJ, Choi KY. The PI3 kinase-Akt pathway mediates Wnt3a-induced proliferation. Cell Signal. 2007;19(3):511–518. doi:10.1016/j.cellsig.2006.08.008.
   PubMed Web of Science ®Google Scholar
• Ahmed D, Eide PW, Eilertsen IA, Danielsen SA, Eknæs M, Hektoen M, Lind GE, Lothe RA. Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis. 2013;2(9):e71. doi:10.1038/oncsis.2013.35.
   PubMedGoogle Scholar
• Berg KCG, Eide PW, Eilertsen IA, Johannessen B, Bruun J, Danielsen SA, Bjørnslett M, Meza-Zepeda LA, Eknæs M, Lind GE, et al. Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies. Mol Cancer. 2017;16(1):116. doi:10.1186/s12943-017-0691-y.
   PubMedGoogle Scholar
• Niepel M, Hafner M, Pace EA, Chung M, Chai DH, Zhou L, Muhlich JL, Schoeberl B, Sorger PK. Analysis of growth factor signaling in genetically diverse breast cancer lines. BMC Biol. 2014;12(1):20. doi:10.1186/1741-7007-12-20.
   PubMedGoogle Scholar
• Cain RJ, Ridley AJ. Phosphoinositide 3-kinases in cell migration. Biol Cell. 2009;101(1):13–29. doi:10.1042/BC20080079.
   PubMed Web of Science ®Google Scholar
• Iwai S, Yonekawa A, Harada C, Hamada M, Katagiri W, Nakazawa M, Yura Y. Involvement of the Wnt-β-catenin pathway in invasion and migration of oral squamous carcinoma cells. Int J Oncol. 2010;37(5):1095–1103. doi:10.3892/ijo_00000761.
   PubMed Web of Science ®Google Scholar
• Deming DA, Leystra AA, Nettekoven L, Sievers C, Miller D, Middlebrooks M, Clipson L, Albrecht D, Bacher J, Washington MK, et al. PIK3CA and APC mutations are synergistic in the development of intestinal cancers. Oncogene. 2014;33(17):2245–2254. doi:10.1038/onc.2013.167.
   PubMed Web of Science ®Google Scholar
• Liu JJ, Ho JY, Lee HW, Baik MW, Kim O, Choi YJ, Hur SY. Inhibition of phosphatidylinositol 3-kinase (PI3K) signaling synergistically potentiates antitumor efficacy of paclitaxel and overcomes paclitaxel-mediated resistance in cervical cancer. Int J Mol Sci. 2019;20:14.
   Web of Science ®Google Scholar
• Pearson HB, Phesse TJ, Clarke AR. K-ras and Wnt signaling synergize to accelerate prostate tumorigenesis in the mouse. Cancer Res. 2009;69(1):94–101. doi:10.1158/0008-5472.CAN-08-2895.
   PubMed Web of Science ®Google Scholar
• Kim JG, Kim MJ, Choi WJ, Moon MY, Kim HJ, Lee JY, Kim J, Kim SC, Kang SG, Seo GY, et al. Wnt3A induces GSK-3β phosphorylation and β-Catenin accumulation through RhoA/ROCK. J Cell Physiol. 2017;232(5):1104–1113. doi:10.1002/jcp.25572.
   PubMed Web of Science ®Google Scholar
• Krishnamurthy N, Kurzrock R. Targeting the Wnt/beta-catenin pathway in cancer: update on effectors and inhibitors. Cancer Treat Rev. 2018;62:50–60. doi:10.1016/j.ctrv.2017.11.002.
   PubMed Web of Science ®Google Scholar
• Bezerra Lima B, Faria Fonseca B, da Graça Amado N, Moreira Lima D, Albuquerque Ribeiro R, Garcia Abreu J, de Castro Brito GA, McCormick BA. Clostridium difficile toxin A attenuates Wnt/β-catenin signaling in intestinal epithelial cells. Infect Immun. 2014;82(7):2680–2687. doi:10.1128/IAI.00567-13.
   PubMed Web of Science ®Google Scholar
• Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–404. doi:10.1158/2159-8290.CD-12-0095.
   PubMed Web of Science ®Google Scholar
• Giannakis M, Mu XJ, Shukla SA, Qian ZR, Cohen O, Nishihara R, Bahl S, Cao Y, Amin-Mansour A, Yamauchi M, et al. Genomic correlates of immune-cell infiltrates in colorectal carcinoma. Cell Rep. 2016;17(4):1206. doi:10.1016/j.celrep.2016.10.009.
   PubMed Web of Science ®Google Scholar
• Seshagiri S, Stawiski EW, Durinck S, Modrusan Z, Storm EE, Conboy CB, Chaudhuri S, Guan Y, Janakiraman V, Jaiswal BS, et al. Recurrent R-spondin fusions in colon cancer. Nature. 2012;488(7413):660–664. doi:10.1038/nature11282.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330–337. doi:10.1038/nature11252.
   PubMed Web of Science ®Google Scholar
• Ganesh K, Wu C, O’Rourke KP, Szeglin BC, Zheng Y, Sauvé CG, Adileh M, Wasserman I, Marco MR, Kim AS, et al. A rectal cancer organoid platform to study individual responses to chemoradiation. Nat Med. 2019;25(10):1607–1614. doi:10.1038/s41591-019-0584-2.
   PubMed Web of Science ®Google Scholar
• Guda K, Veigl ML, Varadan V, Nosrati A, Ravi L, Lutterbaugh J, Beard L, Willson JK, Sedwick WD, Wang ZJ, et al. Novel recurrently mutated genes in African American colon cancers. Proc Natl Acad Sci U S A. 2015;112(4):1149–1154. doi:10.1073/pnas.1417064112.
   PubMed Web of Science ®Google Scholar
• Vasaikar S, Huang C, Wang X, Petyuk VA, Savage SR, Wen B, Dou Y, Zhang Y, Shi Z, Arshad OA, et al. Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities. Cell. 2019;177(4):1035–1049.e19. doi:10.1016/j.cell.2019.03.030.
   PubMed Web of Science ®Google Scholar
• Yang G, Zheng RY, Jin ZS. Correlations between microsatellite instability and the biological behavior of tumors. J Cancer Res Clin Oncol. 2019;145(12):2891–2899. doi:10.1007/s00432-019-03053-4.
   PubMed Web of Science ®Google Scholar